Federal and Regulatory Outreach
DRRC Letter to HHS in Support for Federal Investment into COVID-19 Research on Disability, Independent Living and Rehabilitation
September 8, 2020
Regulatory
AMRPA Letter to Congressional Leadership Regarding IMPACT Act’s Timeline & Prototype Testing
July 30, 2020
IMPACT Act Legislative Quality
AMRPA’s Response to the CMS Proposed Rule on Inpatient Prospective Payment System for FY 2021
July 10, 2020
IPPS/LTCH PPS Regulatory
AMRPA’s Submissions to the CMS Interim Final Rule on COVID-19
July 9, 2020
Regulatory
AMRPA Recommendations to Senate HELP Committee Regarding Pandemic Preparedness Legislation
June 26, 2020
Legislative
AMRPA Submits Comments on Fiscal Year 2021 Inpatient Rehabilitation Facility Prospective Payment System Proposed Rule
June 5, 2020
IRF PPS Regulatory
AMRPA Response to Medicare Advantage Part C Proposed Rule for FY 2021 and 2022
April 6, 2020
Medicare Advantage
Letter to HHS & CMS Administrators Regarding COVID-19
March 13, 2020
AMRPA Response to U.S. News Proposed 2020-2021 Rehabilitation Hospital Ranking Methodology
March 10, 2020
AMRPA Responds to CMS: Advance Notice of Methodological Changes for Calendar Year (CY) 2021 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies – Part II
March 6, 2020
Medicare Advantage
AMRPA Statement on Fiscal Year 2021 HHS Budget Proposal
February 25, 2020
Burden Reduction Medicare Advantage Prior Authorization
AMRPA Submits Comments on CY 2021 Medicare Physician Fee Schedule and Quality Payment Program Proposed Rule